Are you a new member? Sign up now
Login area
| Sign up
close
ZYTUX - 500mg/50ml - 1x50ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FA01 | BioTech | Rituximab - 500mg/50ml | 10030 | 125719/1 | ZYTUX | 500mg/50ml | 1x50ml | Injectable concentrate for solution | Infusion | Lebiran SARL | Aryogen Pharmed | Iran | 27,724,196 L.L | 10.71 | E1 | Aryogen Pharmed | Iran | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FA01 | BioTech | Rituximab - 500mg/50ml | 10809 | 89121/1 | MABIXEN 500 | 500mg/50ml | 2x50ml | Injectable concentrate for solution | Infusion | Benta Trading Co s.a.l. | Manufactured by JSC Biocad, Russia for Benta SAL | Lebanon | 136,761,210 L.L | 2.44 | E2 | 2/5/2024 | 0 | ||
| L01FA01 | BioTech | Rituximab - 500mg/50ml | 11669 | 6424/1 | MABIXEN 500 | 500mg/50ml | 1x50ml | Injectable concentrate for solution | Infusion | Benta Trading Co s.a.l. | Manufactured by JSC Biocad, Russia for Benta SAL | Lebanon | 74,718,320 L.L | 10.71 | E1 | 2/5/2024 | 0 | ||
| L01FA01 | BioTech | Rituximab - 500mg/50ml | 5573 | 219565/09 | MABTHERA | 500mg/50ml | 1 | Injectable concentrated solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | 80,211,932 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 500mg | 11603 | 107123/1 | RITUXIREL | 500mg/10ml | 1x10ml | Injectable concentrated solution | Infusion | Levant Pulse SARL | Reliance Life Sciences pvt Ltd | India | 45,258,360 L.L | 10.71 | E1 | Reliance Life Sciences pvt Ltd | India | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 500mg/50ml | 9383 | 41818/1 | RIXATHON | 500mg/50ml | 1 x 50ml | Injectable concentrate for solution | Infusion | Khalil Fattal & Fils S.A.L. | Lek Pharmaceuticals dd | Slovenia | 75,978,420 L.L | 10.71 | E1 | Sandoz GmbH | Austria | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 500mg/50ml | 9385 | 41918/1 | RIXATHON | 500mg/50ml | 2 x 50ml | Injectable concentrate for solution | Infusion | Khalil Fattal & Fils S.A.L. | Lek Pharmaceuticals dd | Slovenia | 132,113,470 L.L | 2.44 | E2 | Sandoz GmbH | Austria | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 500mg/50ml | 11621 | 13923/1 | RUXIENCE | 500mg/50ml | 1x50ml | Injectable concentrate for solution | Infusion | Droguerie Fattal S.A.L. | Pfizer Manufacturing Belgium NV | Belgium | 59,148,151 L.L | 10.71 | E1 | Pfizer Europe MA EEIG | Belgium | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 500mg/50ml | 10674 | 195919/1 | TRUXIMA | 500mg/50ml | 1x10ml | Injectable concentrate for solution | Infusion | Droguerie Mercury S.A.L. | Celltrion Inc. | Korea | 69,240,828 L.L | 10.71 | E1 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 500mg | 11603/388 | 107123/1 | RITUXIREL | 500mg/10ml | 1x10ml | Injectable concentrated solution | Infusion | Levant Pulse SARL | Reliance Life Sciences pvt Ltd | India | L.L | 10.71 | E1 | Reliance Life Sciences pvt Ltd | India | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024